Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Chembio Diagnostics Files For Potential Stock Offering, Size Not Disclosed

-Reuters

byMichael Horton

September 7, 2022

1 minute read

-Reuters

Wolfe Research Initiates Coverage On Columbia Property Trust with Peer Perform Rating, Announces Price Target of $19.25

By Benzinga Newsdesk

Today, 9:49 AM

Wolfe Research analyst Andrew Rosivach initiates coverage on Columbia Property Trust (NYSE:CXP) with a Peer Perform rating and announces Price Target of $19.25.

CXP

Raymond James Maintains Outperform on DexCom, Raises Price Target to $618

By Benzinga Newsdesk

Today, 9:49 AM

Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $515 to $618.

DXCM

News

Fluidigm Confirms Its Advanta Dx SARS-CoV-2 PCR Assay Detects Omicron Variant

By Benzinga Newsdesk

Today, 9:49 AM

No Published Viral Mutations to Date, Including Omicron Variant, Meaningfully Impact the Regions of the Viral Genome Targeted by the Assay SOUTH SAN FRANCISCO, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Fluidigm

FLDM